Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marialaura Del Basso De Caro is active.

Publication


Featured researches published by Marialaura Del Basso De Caro.


Journal of Neuro-oncology | 2007

Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors

Francesco Maiuri; Marialaura Del Basso De Caro; Felice Esposito; Paolo Cappabianca; Viviana Strazzullo; Guido Pettinato; Enrico de Divitiis

SummaryObjectiveRecurrence of apparently completely resected benign meningiomas is a rather frequent event, the mechanisms of which are still unclear. The aim of this study is to define the pathological features, proliferation indexes, growth factors and hormone receptor expression in predicting the meningioma recurrence.MethodsTwo groups of 50 completely resected benign WHO I meningiomas, with and without recurrence respectively, have been reviewed. Tumor location, consistency, vascularity, and histological types have been considered. Immunohistological studies include mitotic index (MI), Ki-67 LI, estrogen and progesterone receptors (ER and PR), Vascular Endothelial Growth Factor (VEGF), Epidermal Growth Factor (EGF), and Bcl-2. All these factors have been correlated with the recurrence.ResultsThe tumor recurrence was not correlated with the patient age, tumor location, consistency, vascularity and histology. There was not difference in the histological pattern between local and diffuse recurrences. M.I. and Ki-67 LI were significantly correlated with the recurrence (P<0.0001). PR negativity had a strong predictive value of recurrence (P<0.0001), whereas the ER status was not relevant. VEGF and EGF-R were not correlated with the recurrence of meningiomas, whereas the Bcl-2 protein positivity showed a tendency to the significativity (P=0.0294). The negative association between Bcl-2 and PR is an interesting finding of our study.ConclusionsHigher MI and Ki-67 LI and PR negativity are predictive factors of recurrence of benign (WHO I) completely resected meningiomas, particularly when Bcl-2 positivity is associated.


European Journal of Radiology | 1999

Intracranial meningiomas: correlations between MR imaging and histology

Francesco Maiuri; Oreste de Divitiis; S. Cirillo; Francesco Di Salle; Marialaura Del Basso De Caro

The authors have examined the relationship between magnetic resonance imaging (MRI) and histopathological features in 35 surgically verified intracranial meningiomas. Tumor signals on T1-weighted images were rather similar regardless of the histologic subtype of the tumors. On T2-weighted images, hypointense meningiomas were mainly fibroblastic and hyperintense tumors were mainly syncytial and angioblastic, and partly transitional. Isointense tumors were mainly transitional and partly fibroblastic and syncytial. The authors conclude that the signal intensity of the MRI may be useful in the preoperative characterization of intracranial meningiomas. T1-weighted images may predict the presence of cysts and intratumoral blood vessels; whereas T2-weighted images can give information about histological subtype, vascularity and consistency. Meningiomas hyperintense to the cortex on T2 are usually soft, more vascular and more frequently of syncytial or angioblastic subtype; tumors hypointense or hypo-isointense on T2 tend to have a more hard consistency and are more often of fibroblastic or transitional subtype.


Surgical Neurology | 1995

Intracranial meningeal melanocytoma: case report.

Francesco Maiuri; Dino Benvenuti; Eros Lamaida; Marialaura Del Basso De Caro

A case of meningeal melanocytoma of the left sphenoid wing is reported and the other nine cases in the literature are reviewed. Meningeal melanocytoma is a benign melanotic tumor that derives from the melanocytes of the leptomeninges and may occur anywhere in the cranial and spinal meninges. Electron microscopy well demonstrates melanin and melanosomes within the tumor cells. The immunohistochemical pattern of this tumor includes strong positivity for S-100 protein, vimentin, and antimelanoma antibody and negativity for epithelial membrane antigen, neuron-specific enolase, cytokeratin, and glial fibrillary acidic protein. Complete surgical removal is the treatment of choice, whereas radiotherapy is usually unnecessary. In spite of benign biologic behavior of meningeal melanocytoma, the prognosis remains uncertain, because of the possible local recurrences.


Clinical Neurology and Neurosurgery | 1997

Symptomatic subependymomas of the lateral ventricles. Report of eight cases

Francesco Maiuri; Michelangelo Gangemi; Francesco Signorelli; Marialaura Del Basso De Caro

Subependymomas are rare, slow-growing, benign intraventricular tumors, which often are asymptomatic and are discovered incidentally. The review of the literature shows more than 100 symptomatic cases, less than half located in the lateral ventricles. Here we report 8 cases of symptomatic subependymomas of the lateral ventricles, studied by CT and/or MR and treated by direct surgical approach. The suspicion of a subependymoma should arise when a patient older than 10-15 years with long clinical history presents an intraventricular tumor isodense on CT and isointense in T1 and hyperintense in T2 on MR, with scarce or discrete contrast enhancement. Surgical treatment is indicated in symptomatic subependymomas of the lateral ventricles and usually allows complete tumor removal. The prognosis is usually good, also without postoperative irradiation.


Clinical Endocrinology | 2008

Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients

Antongiulio Faggiano; Lidice Tavares; Libuse Tauchmanovà; Francesco Milone; Gelsomina Mansueto; Valeria Ramundo; Marialaura Del Basso De Caro; Gaetano Lombardi; Gaetano De Rosa; Annamaria Colao

Background  In patients with multiple endocrine neoplasia type 1 (MEN1), expression of somatostatin receptor (SST) in parathyroid adenomas and effectiveness of therapy with somatostatin analogues on primary hyperparathyroidism (PHP) have been scarcely investigated.


Clinical Endocrinology | 2001

In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: Correlation with somatostatin and dopamine D2 receptor scintigraphy

Diego Ferone; Rosario Pivonello; Secondo Lastoria; Antongiulio Faggiano; Marialaura Del Basso De Caro; Paolo Cappabianca; Gaetano Lombardi; Annamaria Colao

OBJECTIVE GH and PRL cosecretion frequently occurs in acromegaly and the sensitivity of both hormones to somatostatin analogs (SA) and dopamine agonists (DA) alone or in combination, is still debated. This study was designed to evaluate the in vivo and in vitro sensitivity to SA and/or DA and correlate the response in terms of hormone suppression to the results of in vivo somatostatin and dopamine receptor scintigraphy and to the immunohistochemical findings.


Neurological Research | 1990

Familial cerebral cavernous angiomas

Michelangelo Gangemi; Francesco Maiuri; Pierarturo Donati; Giuseppe Cinalli; Marialaura Del Basso De Caro; Luigi Sigona

Three families with two or more members affected by cavernous angiomas of the brain are described and the other 17 reported in the literature are reviewed. The familial occurrence of cerebral cavernous angiomas has been considered a rare event; nevertheless, the experience of the authors (positive familiarity in three patients where two or more relatives have been explored radiologically) suggests that cavernous angiomas of the brain might be, at least in most cases, a familial disease. Therefore, when a patient with cerebral cavernous angioma is observed, a careful familial history and the exploration of the familial members by computerized tomography or better still by magnetic resonance must be performed. The high frequency of multiple lesions in familial cases, the surgical indications and the role of the ultrasonic prenatal diagnosis are also discussed.


Journal of Neuro-oncology | 2004

Single brain metastases of carcinoid tumors.

Francesco Maiuri; Paolo Cappabianca; Marialaura Del Basso De Caro; Felice Esposito

Carcinoid tumors are one among the most uncommon source of metastatic lesion to the brain. Four cases of single brain metastases from carcinoid tumors operated upon and verified by both histology and immunohistochemical staining are reported. The site of the primary carcinoid tumor was the lung in two cases, ileum in one and the left colon in another. The location of the brain metastasis was supratentorial in two cases and cerebellar in two. A high vascular tumor with large blood channels was found at surgery. Immunohistochemical studies showed in all four cases positive staining for synaptophysin, neuron-specific enolase, chromogranine and cytocheratine and negative staining for S-100 and HMB-45. The postoperative survival time ranged from 5 to 18 months. The epidemiological, surgical and pathological features of brain metastases from carcinoid tumors are also discussed from the analysis of 44 well-documented cases reported in the literature.


Journal of Neuro-oncology | 2004

Second-line chemotherapy with the association of liposomal daunorubicin, carboplatin and etoposide in children with recurrent malignant brain tumors.

Amedeo Fiorillo; Giuseppe Maggi; Nicola Greco; Roberta Migliorati; Alessandra D'Amico; Marialaura Del Basso De Caro; M. Simona Sabbatino; Floriana Buffardi

Progressive or recurrent high-grade gliomas are characterized by a very poor prognosis, and the relevance of second-line chemotherapy is still unassessed.Although it has been reported that liposomal anthracyclines and carboplatin show some activity in these patients, their association has never been investigated.We have treated six children with recurrent high-grade glioma after surgery, radiotherapy and chemotherapy, and one child with progressive teratoid/rhabdoid tumor with the combination of liposomal daunorubicin and carboplatin plus etoposide. Five out of seven children showed a major response and the 29 month progression-free survival was 38%. The above regimen was feasible and children showed only little and transient hematological toxicity.In our opinion, these results justify further investigation of the above combination chemotherapy for recurrent or progressive malignant brain tumors in children.


Materials Science and Engineering: C | 2014

Melt-spun bioactive sutures containing nanohybrids for local delivery of anti-inflammatory drugs

Ovidio Catanzano; Stefano Acierno; Pietro Russo; Mariarosaria Cervasio; Marialaura Del Basso De Caro; Adele Bolognese; Gilberto Sammartino; Luigi Califano; Gaetano Marenzi; Antonio Calignano; D. Acierno; Fabiana Quaglia

In this work, a novel concept is introduced in drug-eluting fibres to ensure a good control of drug delivery features and wide applicability to different bioactive compounds. Composite bioactive sutures based on fibre grade poly(ε-caprolactone) (PCL) and loaded with the anti-inflammatory drug Diclofenac (Dic) or a Dic nanohybrid where the drug is intercalated in a synthetic hydrotalcite (Mg/Al hydroxycarbonate) (HT-Dic) were developed. Fibres were prepared by melt-spinning at different PCL/HT-Dic/Dic ratios and analysed in terms of morphology, mechanical properties and drug release features. Results emphasized that tensile properties of fibres are clearly affected by Dic or HT-Dic addition, while the presence of knots has limited influence on the mechanical behaviour of the sutures. Release of Dic strongly depends on how Dic is loaded in the fibre (as free or nanohybrid) whereas the combination of free Dic and HT-Dic can allow a further tuning of release profile. In vivo experiments show a reduction of inflammatory responses associated with Dic-loaded fibers. Thus, a proof of principle is provided for a novel class of bioactive sutures integrating advanced controlled-release technologies.

Collaboration


Dive into the Marialaura Del Basso De Caro's collaboration.

Top Co-Authors

Avatar

Elia Guadagno

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Paolo Cappabianca

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Francesco Maiuri

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Domenico Solari

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Enrico de Divitiis

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Annamaria Colao

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Guido Pettinato

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Mariarosaria Cervasio

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giorgio Borrelli

University of Naples Federico II

View shared research outputs
Researchain Logo
Decentralizing Knowledge